Evidence map›Paper›PMID 29680977›Full record

ArticleMikrochimica acta2018

A signal-on ratiometric fluorometric heparin assay based on the direct interaction between amino-modified carbon dots and DNA.

Jianyong Huang, Fenglan Li, Rubin Guo, Yuyuan Chen, Zhenzhen Wang, Chengfei Zhao, Yanjie Zheng, Shaohuang Weng, Xinhua Lin

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jianyong HuangDepartment of Pharmaceutical, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Fenglan LiDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China.
Rubin GuoDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China.
Yuyuan ChenDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China.
Zhenzhen WangDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China.
Chengfei ZhaoDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China.
Yanjie ZhengDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China.
Shaohuang WengDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China. shweng@fjmu.edu.cn.
Xinhua LinDepartment of Pharmaceutical Analysis, School of Pharmacy, the Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China.
Fujian Medical University · CNUnion Hospital · CN

Funding

National Natural Science Foundation of China 21405016, 21775023, 21705021National Science Foundation of Fujian Province 2015J01043, 2016J01767, 2017Y0042the Elite Cultivation Program of Health and Family Planning of Fujian Province 2017-ZQN-61
6 · The paper itself

Abstract

Amino-modified carbon dots (C-dots) with positively charged surface were prepared. They display strong blue fluorescence and are shown to act as quenchers of the green fluorescence of FAM-labeled ssDNA such as the F-probe used in this work that was immobilized on the C-dots. On the addition of highly negatively charged heparin (Hep), it will interact with the C-dots and displace the F-probe from C-dots. Once the F-probe is displaced by Hep, its green fluorescence is restored. The intrinsic blue fluorescence of the C-dots remains stable after addition of Hep. Thus, a signal-on ratiometric fluorometric assay was developed for the ultra-sensitive detection of Hep. The underlying mechanisms of quenching and recovery are discussed. Under optimized conditions, the recovery of the ratiometric fluorescence of the system composed of C-dots and quenched F-probe is proportional to the Hep concentration in the range of 0.01-2.0 μg·mL

Indexed as

Biological AssayFluorometryAnimalsCarbonDNAFluorescent DyesHeparinLimit of DetectionQuantum DotsRabbitsCarbonDNAFluorescent DyesHeparinFluorescence assayFluorescent carbon nanomaterialRatiometric strategySensitive detectionssDNA quenching platform

Identifiers

PMID29680977
OpenAlexW2801854899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.